Antifungals represent a critical class of medications designed to combat fungal infections, offering relief from ailments caused by a diverse array of fungi. Azoles, such as fluconazole, interfere with fungal cell membrane synthesis, disrupting their structural integrity and impeding growth. Polyenes, like amphotericin B, bind to fungal cell membranes, causing membrane leakage and eventual cell death. Echinocandins, a newer class, inhibit the synthesis of fungal cell walls, curbing the progression of invasive fungal infections. Antifungals find applications in treating common conditions like athlete's foot and yeast infections, as well as more severe systemic infections such as candidiasis and aspergillosis. However, challenges persist, including the emergence of antifungal resistance, particularly in immunocompromised individuals. Ongoing research strives to unravel new antifungal targets and develop innovative strategies to address the dynamic landscape of fungal infections.